SCHEMBL7522308

SCHEMBL7522308

COc1ccc(CN2Cc3sc(NC(=O)C(=O)O)c(C(=O)O)c3CC2CNC(=O)c2ccc(NC(=O)c3ccccc3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLO1 Q04760 1/20 0.46
PTPN1 P18031 4/20 0.46
PTPN2 P17706 3/20 0.44
KMT2A Q03164 2/20 0.44
HSD17B10 Q99714 1/20 0.44
NOD1 Q9Y239 2/20 0.43
TNF P01375 1/20 0.43
NOD2 Q9HC29 1/20 0.43
TP53 P04637 3/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAPT P10636 4/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PPARA Q07869 1/20 0.41
THRB P10828 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7525127 0.93 PTPN1 (0.47) GLO1PTPN1PTPN2KMT2ANOD1
SCHEMBL7521067 0.85 PTPN1 (0.47) GLO1PTPN1PTPN2MAPTALDH1A1
SCHEMBL7526850 0.83 PTPN1 (0.46) GLO1PTPN1PTPN2KMT2AMAPT
SCHEMBL5837693 0.83 KMT2A (0.46) GLO1PTPN1PTPN2KMT2AHSD17B10
SCHEMBL7521561 0.83 NT5E (0.43) GLO1PTPN1KMT2ATP53TDP1
SCHEMBL7521500 0.83 PTPN1 (0.43) GLO1PTPN1PTPN2KMT2AALDH1A1
SCHEMBL7521290 0.83 PTPN1 (0.54) PTPN1PTPN2KMT2ANPC1RAB9A
SCHEMBL7519972 0.81 PTPN1 (0.44) GLO1PTPN1PTPN2KMT2ANOD1
SCHEMBL7524893 0.81 PTPN1 (0.45) PTPN1PTPN2KMT2ATP53MAPT
SCHEMBL5837948 0.80 PTPN1 (0.49) GLO1PTPN1PTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) NOVO NORDISK A/S (DK) 2002-07-25 US claimed
WO-2002004458-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-17 WO claimed
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) NOVO NORDISK A/S (DK) 2002-07-25 US disclosed
WO-2002004458-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPN1, PTPRO, PTPRS GLO1 1921/4885PTPN1 1/4885PTPN2 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.